Amgen Decode Study Identifies Proteomic Predictors of All-Cause Mortality Using Somalogic's SomaScan to analyze nearly 23,000 subjects, the researchers identified signatures indicating high and low risks of death within 10 years. FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen The approval makes Lumakras the first inhibitor of KRAS, once considered "undruggable," to reach the market for KRAS-mutated NSCLC. Long-Read Sequencing Characterizes Structural Variants in Icelandic Population By extrapolating from long-read genome sequences from 3,622 Icelanders, researchers profiled SV alleles and associated traits or conditions in the broader population. Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC As part of its Biomarker Assist program, Amgen will cover the cost of NeoGenomics' KRAS tests for advanced or metastatic NSCLC patients regardless of their insurance status. Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development The company aims to use the methylation technology from its multi-cancer screening assay to detect minimal residual disease in early-stage cancer patients. Jan 7, 2021 Identical Twins Have Non-Identical Genomes, Study Finds Dec 17, 2020 Danish Researchers to Integrate Genomic Data With New Disease Trajectory Browser Premium Dec 7, 2020 UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects Oct 8, 2020 Olfactory Gene Variants Influence How People Perceive Fishy Smells, Other Odors Oct 5, 2020 Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells Premium Jul 30, 2020 SomaLogic Inks Deal With Amgen to Analyze Protein Expression in Patient Samples Jun 24, 2020 Genetic Study Explains Link Between Osteoporosis Drug, Cardiovascular Risk May 13, 2020 Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19 Premium Apr 15, 2020 Iceland SARS-CoV-2 Screening Effort Finds Lower Infection Incidence in Children, Women Apr 2, 2020 Amgen, Adaptive Biotechnologies Partner on Drug Discovery for COVID-19 Mar 6, 2020 As Consumer Genomics Market Cools, Providers Ponder Better Ways to Reach Customers Premium Jan 14, 2020 Qiagen, Amgen Collaborate to Develop CDx for Investigational NSCLC Drug Jan 13, 2020 Guardant Health to Develop Liquid Biopsy CDx for Amgen KRAS G12C Inhibitor Dec 5, 2019 Amgen Gifts $1M to Keck Graduate Institute for Genomics Education Center Sep 17, 2019 Amgen, Adaptive Biotechnologies Expand Partnership on NGS Blood Cancer Monitoring Sep 11, 2019 UK Biobank Whole-Genome Sequencing Project Obtains £200M from Pharma, Government, Philanthropy Jun 12, 2019 Intermountain, Decode Genetics to Sequence 500K Genomes for Research Jun 12, 2019 Intermountain Increases Investment in Precision Health Through Decode Genetics Sequencing Study Premium May 3, 2019 Amgen, Syapse Collaborate on Precision Oncology Jan 15, 2019 Mutation in Inflammation-Related Gene Protects Against Nasal Polyps, Chronic Rhinosinusitis Load More Breaking News MicroGenDx Acquires Sequencing Lab RTL Genomics Pacific Biosciences, Rady Children's Collaborate on Study of WGS-Based Rare Disease Dx Codex DNA Closes $122.7M IPO Infinity BiologiX to Offer Cytox Alzheimer's Disease Genetic Risk Test in US Archaic Hominin History, Interactions Revealed With Denisova Cave Sediment Sequences Liquid Biopsy Startup Adela Launches With $60M Series A Financing Round The Scan NFTs for Genome Sharing Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data. Wastewater Warning System Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19. Networks to Boost Surveillance Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance. Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.